Sign in

    Georgia Bank • Jefferies

    Georgia Bank is an Analyst at Jefferies, specializing in investment banking research and analysis across key market sectors. She has contributed to coverage of multiple major companies, delivering market insights and supporting deal execution with quantitative performance reviews. Georgia began her finance career in recent years after earning her MS in Finance, with previous experience at other investment firms before joining Jefferies in New York. She maintains relevant FINRA certifications and securities licenses, underscoring her credentials as a financial analyst.

    Georgia Bank's questions to Esperion Therapeutics Inc (ESPR) leadership

    Georgia Bank's questions to Esperion Therapeutics Inc (ESPR) leadership • Q2 2025

    Question

    Georgia Bank, on behalf of Dennis Dink at Jefferies, asked for management's view on the consensus U.S. revenue forecast of approximately $170 million for the year, the underlying script growth required, and when the company might provide formal revenue guidance. She also sought clarity on the cadence and certainty of milestone payments from Otsuka.

    Answer

    CFO Ben Halladay stated that the company is tracking well against consensus revenue but is not providing formal guidance at this time. He expressed high confidence in achieving the full $120 million in milestone payments from Otsuka in the second half of the year, citing clear contract language. President & CEO Sheldon Koenig added that while not giving script guidance, the company expects to maintain the double-digit script growth momentum seen this quarter.

    Ask Fintool Equity Research AI